local_hospital

Centrul Clinic De Boli Reumatismale Dr. Ion Stoia

Address
Strada Masaryk Thomas 5, 020983 Bucharest, Romania

Centrul Clinic De Boli Reumatismale Dr. Ion Stoia - Rheumatoid Arthritis Research Center

Centrul Clinic De Boli Reumatismale Dr. Ion Stoia is a specialized clinical research facility dedicated to advancing the understanding and treatment of rheumatic diseases, with a particular emphasis on rheumatoid arthritis. The center has established expertise in conducting clinical trials focused on optimizing therapeutic strategies and monitoring approaches to improve long-term disease control and patient outcomes.

  • Proactive therapeutic drug monitoring (TDM) for TNF inhibitor optimization in rheumatoid arthritis patients
  • Disease activity assessment and remission achievement using standardized clinical indices
  • Subcutaneous biologic therapies and maintenance of sustained disease control

The research center is actively involved in innovative trials such as the RA-DRUM study, which evaluates whether proactive therapeutic drug monitoring can maintain sustained disease control without flares in patients treated with subcutaneous TNF inhibitors. Additionally, their work includes investigations into achieving Clinical Disease Activity Index (CDAI) remission, demonstrating their commitment to implementing evidence-based treatment strategies and precision medicine approaches in the management of rheumatoid arthritis.

Site Overview

assignment
3
connected trials
corporate_fare
8
sponsors
science
2
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
8
Active sponsors
6

Sponsor Network

Top 6 by active trials.

lock +5 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +2 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 442 other sites in Romania

description
Trial volume
3
Outperforms 50% of sites
public
Therapeutic diversity
2areas
Outperforms 51% of sites
groups
Sponsor diversity
8sponsors
Outperforms 81% of sites

Therapeutic Area Benchmark — Romania

Select a therapeutic area to compare against other sites in Romania.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Romania

Market Share

Country: Romania

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centrul Clinic De Boli Reumatismale Dr. Ion Stoia

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Methotrexate Efficacy in Achieving Clinical Disease Activity Index Remission in Patients with Active Rheumatoid ArthritisDiakonhjemmet Sykehus AS, Karolinska University Hospital, Leids Universitair Medisch Centrum (LUMC), Medical University Of ViennaPhase IIIRecruitingJun 2024

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Adalimumab1Unknown2024-08-202024-08-20

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.